PF-Atlas › Clinical Trials › NCT02504827
Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis
Ceftazidime/avibactam · Phase 4
Registry ID
NCT02504827
Phase
Phase 4
Status
Completed
Drug / intervention
Ceftazidime/avibactam
Sponsor
University of Southern California
Start
2015-09
Enrollment
12
Locations
1
About this trial
The purpose of this research study is to characterize the pharmacokinetics of intravenous ceftazidime/avibactam in patients with Cystic Fibrosis.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT02504827 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.